Gefsan 250mg Tablet is a cancer treatment that targets epidermal growth factor receptor EGFR in normal and cancer cells disrupting signals necessary for cancer cell growth Gefitinib a cancer medication inhibits cancer cell growth by targeting the EGFR present in healthy and cancerous cells It interferes with specific proteins related to this receptor interrupting the communication pathways crucial for cancer cell growth and survival It is important to follow the prescribed dose and duration as directed by the doctor and maintaining a consistent daily time for optimal results Common side effects may include diarrhea dry skin loss of appetite nausea rash mouth inflammation vomiting weakness and weight loss It may increase the risk of interstitial lung disease so patients should be monitored for symptoms and seek prompt medical attention if necessary If a dose is missed take it when remembered but do not double doses Consult the doctor for guidance on managing missed doses effectively
